A phase II, multicenter, single-arm trial of eribulin as first-line chemotherapy for HER2-negative locally advanced or metastatic breast cancer.
about
A phase II, multicenter, single-arm trial of eribulin as first-line chemotherapy for HER2-negative locally advanced or metastatic breast cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A phase II, multicenter, singl ...... d or metastatic breast cancer.
@ast
A phase II, multicenter, singl ...... d or metastatic breast cancer.
@en
type
label
A phase II, multicenter, singl ...... d or metastatic breast cancer.
@ast
A phase II, multicenter, singl ...... d or metastatic breast cancer.
@en
prefLabel
A phase II, multicenter, singl ...... d or metastatic breast cancer.
@ast
A phase II, multicenter, singl ...... d or metastatic breast cancer.
@en
P2093
P2860
P1433
P1476
A phase II, multicenter, singl ...... d or metastatic breast cancer.
@en
P2093
Hidemi Kawajiri
Katsumi Ikeda
Kenji Tezuka
Kosei Hirakawa
Minoru Takada
Naoyoshi Onoda
Satoru Noda
Shigehiko Nishimura
Shigehito Yamagata
P2860
P2888
P356
10.1186/S40064-016-1833-1
P577
2016-02-24T00:00:00Z
P5875
P6179
1015752330